achiev synergi ahead schedul
iqvia beat revenu profit expect guid expect
report anoth record book quarter compani one year ahead
post merger goal bp revenu growth acceler achiev part
effect cross sell new technolog innov lower
target multipl line cro peer group trade roll
calcul forward ep result pt increas
number revenu beat pjc consensu estim
ebitda beat pjc estim consensu ep
beat pjc estim consensu revenu
guid rang compani provid guidanc
low end metric expect expect revenu vs
pjc/consensu ebitda vs pjc/consensu ep
vs pjc/ consensu
quintil im merger drive cross-sel synergi sign five
larg pharma deal account pre-merg one two
compani footprint case consid lock
exampl gsk previous pursu new busi quintil im
strong relationship c-suit level compani abl leverag
relationship combin new technolog capabl expand
relationship clinic research offer roch quintil prior
relationship abl leverag oce win although larg pharma
drive major book remain cautiou execut mani larg
deal compani launch mani new technolog capabl
acceler book suggest sustain long-term growth
solut anoth record book quarter net new busi
exclud pass-through repres y/i growth result book-to-
bill market segment largest contributor book growth
larg pharma segment grew emerg biopharma grew product
segment full clinic drove major y/i growth follow lab
grew includ pass-through compani solut
chang pharma industri impact spend drug research revers
current increas outsourc trend pharma industri averag leverag
balanc sheet impact opportun
iqvia largest cro industri expertis across major therapeut
oper countri
ep
debt total capit
piper jaffray seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
sale
compani document piper jaffray co
compani document piper jaffray co
compani document piper jaffray co
compani document factset piper jaffray co
page
revenu
revenu reimburs expens
consolid incom oper
loss extinguish debt
sale busi
incom tax
tax incom
equiti earn unconsolid affili
loss incom non-control interest
revenu
current disclosur inform compani locat
